CMF-02307 | ERG | up-regulates | PRRX1 | activates | R-3071 | 18 | 4 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-02308 | ERG | up-regulates | PRRX1 | activates | R-3073 | 18 | 4 | Drugs (3) |
CMF-04268 | RBPJL | up-regulates | PRRX1 | activates | R-3071 | 18 | 12 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-04269 | RBPJL | up-regulates | PRRX1 | activates | R-3073 | 18 | 12 | Drugs (3) |
CMF-04271 | RBPJL | up-regulates | PRRX1 | activates | R-3072 | 18 | 12 | Drugs (2) |
CMF-04275 | RBPJL | up-regulates | PRRX1 | activates | R-3080 | 18 | 12 | Drugs (2) |
CMF-04413 | COL12A1 | up-regulates | PRRX1 | activates | R-3071 | 18 | 4 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-04414 | COL12A1 | up-regulates | PRRX1 | activates | R-3072 | 18 | 4 | Drugs (2) |
CMF-08282 | KIF4A | down-regulates | PRRX1 | activates | R-3071 | 18 | 5 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-08283 | KIF4A | down-regulates | PRRX1 | activates | R-3073 | 18 | 5 | Drugs (3) |
CMF-08642 | SLC4A7 | up-regulates | PRRX1 | activates | R-3072 | 18 | 2 | Drugs (2) |
CMF-11361 | ZCCHC5 | up-regulates | PRRX1 | activates | R-3080 | 18 | 1 | Drugs (2) |
CMF-13071 | OTC | up-regulates | PRRX1 | activates | R-3071 | 18 | 2 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-13504 | FMN1 | up-regulates | PRRX1 | activates | R-3072 | 18 | 7 | Drugs (2) |
CMF-15217 | OR51F1 | down-regulates | PRRX1 | activates | R-3080 | 18 | 2 | Drugs (2) |
CMF-16289 | COBLL1 | up-regulates | PRRX1 | activates | R-3072 | 18 | 2 | Drugs (2) |
CMF-19160 | PTPRR | up-regulates | PRRX1 | activates | R-3072 | 18 | 5 | Drugs (2) |
CMF-19431 | NF1 | up-regulates | PRRX1 | activates | R-3071 | 18 | 10 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-19432 | NF1 | up-regulates | PRRX1 | activates | R-3073 | 18 | 10 | Drugs (3) |
CMF-19434 | NF1 | up-regulates | PRRX1 | activates | R-3072 | 18 | 10 | Drugs (2) |
CMF-19437 | NF1 | up-regulates | PRRX1 | activates | R-3080 | 18 | 10 | Drugs (2) |
CMF-19769 | BVES | up-regulates | PRRX1 | activates | R-3073 | 18 | 7 | Drugs (3) |
CMF-20240 | THSD7B | down-regulates | PRRX1 | activates | R-3080 | 18 | 3 | Drugs (2) |
CMF-21520 | KLHL34 | down-regulates | PRRX1 | activates | R-3071 | 18 | 2 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-21521 | KLHL34 | down-regulates | PRRX1 | activates | R-3072 | 18 | 2 | Drugs (2) |
CMF-22021 | MOCS3 | down-regulates | PRRX1 | activates | R-3072 | 18 | 4 | Drugs (2) |
CMF-22022 | MOCS3 | down-regulates | PRRX1 | activates | R-3080 | 18 | 4 | Drugs (2) |
CMF-22109 | OR2T34 | down-regulates | PRRX1 | activates | R-3071 | 18 | 4 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-22110 | OR2T34 | down-regulates | PRRX1 | activates | R-3073 | 18 | 4 | Drugs (3) |
CMF-25944 | A1CF | down-regulates | PRRX1 | activates | R-3073 | 18 | 3 | Drugs (3) |
CMF-25945 | A1CF | down-regulates | PRRX1 | activates | R-3072 | 18 | 3 | Drugs (2) |
CMF-26591 | NAALADL1 | up-regulates | PRRX1 | activates | R-3073 | 18 | 4 | Drugs (3) |
CMF-26593 | NAALADL1 | up-regulates | PRRX1 | activates | R-3080 | 18 | 4 | Drugs (2) |
CMF-27036 | DNAH5 | up-regulates | PRRX1 | activates | R-3071 | 18 | 7 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-27038 | DNAH5 | up-regulates | PRRX1 | activates | R-3072 | 18 | 7 | Drugs (2) |
CMF-27624 | ANKRD36 | up-regulates | PRRX1 | activates | R-3071 | 18 | 4 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |
CMF-27625 | ANKRD36 | up-regulates | PRRX1 | activates | R-3073 | 18 | 4 | Drugs (3) |
CMF-27697 | FAM83H | down-regulates | PRRX1 | activates | R-3073 | 18 | 3 | Drugs (3) |
CMF-27699 | FAM83H | down-regulates | PRRX1 | activates | R-3080 | 18 | 3 | Drugs (2) |
CMF-29463 | OR2T3 | down-regulates | PRRX1 | activates | R-3071 | 18 | 1 | Drugs (34) Regulator Drugs (0)Regulon Drugs (34)SAVOLITINIB, TELISOTUZUMAB VEDOTIN, AMUVATINIB, BIRINAPANT, CABOZANTINIB, ALTIRATINIB, SGX-523, TEREVALEFIM, TEPOTINIB HYDROCHLORIDE, FORETINIB, ONARTUZUMAB, SAR-125844, AMG-208, MK-8033, AMG-337, CAPMATINIB HYDROCHLORIDE, AMIVANTAMAB, MK-2461, MERESTINIB, BMS-777607, CAPMATINIB, JNJ-38877605, GLESATINIB, BMS-817378, CABOZANTINIB S-MALATE, CRIZOTINIB, EMD-1204831, TIVANTINIB, TELISOTUZUMAB, TEPOTINIB, EMIBETUZUMAB, BPI-9016, PF-04217903, GOLVATINIB |